- $141.10bn
- $151.37bn
- $20.50bn
- 96
- 14
- 95
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,884 | 14,351 | 17,108 | 18,449 | 20,498 |
Cost of Revenue | |||||
Gross Profit | 9,734 | 9,110 | 11,001 | 11,637 | 13,099 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12,171 | 12,128 | 14,520 | 15,608 | 16,610 |
Operating Profit | 2,713 | 2,223 | 2,588 | 2,841 | 3,888 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,562 | 1,954 | 2,281 | 2,683 | 3,673 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,083 | 1,599 | 1,994 | 2,358 | 3,165 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,083 | 1,599 | 1,994 | 2,358 | 3,165 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,083 | 1,599 | 1,994 | 2,358 | 3,165 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.75 | 6.04 | 7.94 | 8.71 | 9.39 |
Dividends per Share |